CD8A and neoplasm: The diminished lymphocyte count indicates a compromised function of CD8 cytotoxic lymphocytes in tumor cell eradication, resulting in a weakened T lymphocyte-mediated anti-tumor response and an overall loss in the body’s anti-tumor capacity.